ANFUSO, CARMELINA DANIELA
 Distribuzione geografica
Continente #
NA - Nord America 7.106
EU - Europa 4.457
AS - Asia 3.074
AF - Africa 582
SA - Sud America 551
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 6
Totale 15.784
Nazione #
US - Stati Uniti d'America 6.891
SG - Singapore 1.591
RU - Federazione Russa 1.554
IT - Italia 1.490
CN - Cina 875
BR - Brasile 469
IE - Irlanda 467
CI - Costa d'Avorio 417
UA - Ucraina 324
VN - Vietnam 229
DE - Germania 184
CA - Canada 170
GB - Regno Unito 110
SN - Senegal 81
SE - Svezia 79
KR - Corea 78
IN - India 73
PL - Polonia 51
FI - Finlandia 42
JP - Giappone 38
AR - Argentina 35
TR - Turchia 32
BD - Bangladesh 28
MX - Messico 28
FR - Francia 27
ZA - Sudafrica 25
CH - Svizzera 24
NL - Olanda 24
UZ - Uzbekistan 18
ID - Indonesia 17
CZ - Repubblica Ceca 16
ES - Italia 16
BJ - Benin 13
EC - Ecuador 13
NG - Nigeria 13
MA - Marocco 12
AT - Austria 11
KE - Kenya 11
HK - Hong Kong 10
LT - Lituania 10
IQ - Iraq 9
IR - Iran 9
VE - Venezuela 9
AE - Emirati Arabi Uniti 8
CO - Colombia 8
AU - Australia 7
BE - Belgio 7
LB - Libano 7
PK - Pakistan 7
SA - Arabia Saudita 7
NP - Nepal 6
EG - Egitto 5
EU - Europa 5
GR - Grecia 5
PY - Paraguay 5
AL - Albania 4
CL - Cile 4
CR - Costa Rica 4
KZ - Kazakistan 4
TN - Tunisia 4
DO - Repubblica Dominicana 3
HN - Honduras 3
IL - Israele 3
MY - Malesia 3
OM - Oman 3
PE - Perù 3
RS - Serbia 3
UY - Uruguay 3
BB - Barbados 2
BO - Bolivia 2
JO - Giordania 2
NO - Norvegia 2
PA - Panama 2
PH - Filippine 2
PS - Palestinian Territory 2
TH - Thailandia 2
TW - Taiwan 2
AM - Armenia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BS - Bahamas 1
CY - Cipro 1
DK - Danimarca 1
EE - Estonia 1
ET - Etiopia 1
JM - Giamaica 1
MD - Moldavia 1
MK - Macedonia 1
MO - Macao, regione amministrativa speciale della Cina 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
RO - Romania 1
SY - Repubblica araba siriana 1
TL - Timor Orientale 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
YE - Yemen 1
Totale 15.784
Città #
Dallas 1.913
Singapore 985
Santa Clara 863
Moscow 706
Chandler 688
Dublin 462
Catania 455
Abidjan 417
Jacksonville 382
Chicago 328
Ashburn 286
Boardman 207
Beijing 162
Hefei 157
Los Angeles 137
Cambridge 126
Lawrence 126
Andover 123
Nanjing 118
Houston 106
Toronto 106
Civitanova Marche 95
Dakar 81
Des Moines 80
Dong Ket 80
Seoul 78
Palermo 64
New York 57
Wilmington 55
São Paulo 53
San Mateo 52
Buffalo 51
Bremen 47
Grafing 47
Ho Chi Minh City 46
Rome 45
Warsaw 45
Munich 44
Milan 39
Hanoi 37
Saint Petersburg 35
Tokyo 35
Council Bluffs 33
Nanchang 33
Shenyang 32
Hebei 30
Ottawa 30
Brooklyn 28
The Dalles 28
Messina 27
Columbus 26
Denver 25
Falls Church 24
Helsinki 22
Jiaxing 22
Aci Catena 21
Orem 21
Mascalucia 20
Padova 20
Phoenix 19
Tianjin 19
Johannesburg 18
San Jose 18
Changsha 17
Chennai 17
Seattle 17
Kochi 16
Poplar 16
London 15
Amsterdam 14
Bari 14
Caltanissetta 14
Casaleone 14
Washington 14
Belo Horizonte 13
Cotonou 13
Abuja 12
Atlanta 12
Boston 12
Manchester 12
Mexico City 12
Naples 12
Brasília 11
Brno 11
Genoa 11
Jakarta 11
Lappeenranta 11
Pune 11
Reggio Calabria 11
Ankara 10
Guangzhou 10
Paternò 10
Shanghai 10
Stockholm 10
Turin 10
Acireale 9
Da Nang 9
Dearborn 9
Dhaka 9
Hong Kong 9
Totale 10.983
Nome #
Antioxidants, Hormetic Nutrition, and Autism 334
Antioxidant, antimicrobial and anticancer activities of Castanea sativa (Fagaceae) extract: new therapeutic perspectives 226
Breaking Barriers: The Role of the Bone Marrow Microenvironment in Multiple Myeloma Progression 219
Aflibercept, bevacizumab and ranibizumab prevent glucose-induced damage in human retinal pericytes in vitro, through a PLA2/COX-2/VEGF-A pathway 204
Correction to: Analysis of common methodological flaws in the highest cited e-cigarette epidemiology research (Internal and Emergency Medicine, (2022), 17, 3, (887-909), 10.1007/s11739-022-02967-1) 186
Comparison Between Folic Acid and gH625 Peptide-Based Functionalization of Fe3O4 Magnetic Nanoparticles for Enhanced Cell Internalization 185
Critical appraisal of the European Union Scientific Committee on Health, Environmental, and Emergency Risks (SCHEER) Preliminary Opinion on electronic cigarettes 182
A tunable nanoplatform of nanogold functionalised with Angiogenin peptides for anti-angiogenic therapy of brain tumours 179
Anti-angiogenic effect of quercetin and its 8-methyl pentamethyl ether derivative in human microvascular endothelial cells 179
1-Acyl-2-lysophosphatidylcholine transport across the blood-retina and blood-brain barrier 176
Antiproliferative and Antiangiogenic Effects of Punica granatum Juice (PGJ) in Multiple Myeloma (MM) 176
Age-related dry eye lactoferrin and lactobionic acid 174
Polychlorinated Biphenyls Induce Cytotoxicity and Inflammation in an In Vitro Model of an Ocular Barrier 173
Anti-VEGF agents inhibit activation of PLA2/COX-2 and expression of VEGF-A induced by high glucose, in human retinal pericytes in vitro 167
Ixazomib improves bone remodeling and counteracts sonic hedgehog signaling inhibition mediated by myeloma cells 164
Clinical appraisal of the European Union Scientific Committee on Health, Environmental and Emerging Risks (SCHEER) Preliminary Opinion on electric cigarettes 162
Anti-angiogenic Therapy in Cancer: Downsides and New Pivots for Precision Medicine 162
Blood-Labyrinth Barrier in Health and Diseases: Effect of Hormetic Nutrients 161
Activation of the VEGF-A/ERK/PLA2 axis mediates early retinal endothelial cell damage induced by high glucose: New insight from an in vitro model of diabetic retinopathy 161
An in vitro retinoblastoma human triple culture model of angiogenesis: A modulatory effect of TGF-β 159
Blood-Brain Barrier in a Haemophilus influenzae Type a In Vitro Infection: Role of Adenosine Receptors A2A and A2B 159
Activation of cytosolic phospholipase A2 and 15-lipoxygenase by oxidized low-density lipoproteins in cultured human lung fibroblasts 157
HALOPERIDOL METABOLITE II VALPROATE ESTER: ANTIANGIOGENIC ACTIVITY IN HUMAN MICROVASCULAR RETINAL ENDOTHELIAL CELLS 156
Sulodexide prevents activation of the PLA2/COX-2/VEGF inflammatory pathway in human retinal endothelial cells by blocking the effect of AGE/RAGE 153
Classical VEGF, Notch and Ang Signalling in cancer angiogenesis, alternative approaches and future directions (review) 150
Antiangiogenic Effect of (±)-Haloperidol Metabolite II Valproate Ester [(±)-MRJF22] in Human Microvascular Retinal Endothelial Cells 150
Anti-angiogenic and anti-proliferative graphene oxide nanosheets for tumor cell therapy 148
Activation of phospholipase A2 and MAP kinases by oxidized low density lipoproteins in immortalized GP8.39 endothelial cells 144
Melatonin loaded hybrid nanomedicine: DoE approach, optimization and in vitro study on diabetic retinopathy model 142
Haloperidol Metabolite II Valproate Ester (S)-(-)-MRJF22: Preliminary Studies as a Potential Multifunctional Agent Against Uveal Melanoma 141
Asthenozoospermia and membrane remodeling enzymes: A new role for phospholipase A2 139
Biochemical and clinical relevance of alpha lipoic acid: antioxidant and anti-inflammatory activity, molecular pathways and therapeutic potential 136
Aging does not affect the susceptibility to lipid peroxidation and lysosomal enzyme release of rat visual system structures and sciatic nerve 135
PJ-34 inhibits PARP-1 expression and ERK phosphorylation in glioma-conditioned brain microvascular endothelial cells. 134
Identification of novel chemotherapeutic strategies for metastatic uveal melanoma 132
Cytosolic and Calcium-Independent PhospholipasesA2 Activation and Prostaglandins E2 Are Associated with Escherichia coli-Induced Reduction of Insulin Secretion in INS-1E Cells 132
Glucose-impaired Corneal Re-epithelialization Is Promoted by a Novel Derivate of Dimethyl Fumarate 132
N-hydroxymethylglycinate with EDTA is an efficient eye drop preservative with very low toxicity: an in vitro comparative study 131
Activation of phospholipase A2 and MAP kinases by oxidized low density lipoprotein in immortalized GP8.39 endothelial cells 130
Role of 17β-Estradiol on Cell Proliferation and Mitochondrial Fitness in Glioblastoma Cells 130
Phenotypic characterization of the SIRC (Statens Seruminstitut Rabbit Cornea) cell line reveals a mixed epithelial and fibroblastic nature 128
Prognostic significance of deregulated microRNAs in uveal melanomas 127
The anti-inflammatory effect of the β1-adrenergic receptor antagonist metoprolol on high glucose treated human microvascular retinal endothelial cells 126
Mesenchymal stem cells (MSC) promotes tumor microenvironment transformation driving Granulocyte-like Myeloid Derived Suppressor Cells (G-MDSC) activation in Smoldering and Multiple Myeloma patients 125
Effect of lipoic acid on the biochemical mechanisms of resistance to bortezomib in SH-SY5Y neuroblastoma cells 124
Immobilisation of neurotrophin peptides on gold nanoparticles by direct and lipid-mediated interaction: a new multipotential therapeutic nanoplatform for CNS disorders 123
Amyloid β(1-42) and its β(25-35) fragment induce in vitro phosphatidylcholine hydrolysis in retina capillary pericytes 122
PARP-1 Expression and ERK Activation are negatively modulated by PJ-34 in an in vitro model of Glioma-Conditioned Blood Brain Barrier 121
Identification of novel microRNAs and their diagnostic and prognostic significance in oral cancer 121
Effects of high glucose concentration on pericyte-like differentiated human adipose-derived mesenchymal stem cells 120
Experimental Evidence of the Healing Properties of Lactobionic Acid for Ocular Surface Disease 119
TLR4 signaling drives mesenchymal stromal cells commitment to promote tumor microenvironment transformation in multiple myeloma 117
Correction: TLR4 signaling drives mesenchymal stromal cells commitment to promote tumor microenvironment transformation in multiple myeloma (Cell Death & Disease, (2019), 10, 10, (704), 10.1038/s41419-019-1959-5) 116
The double effect of walnut septum extract (Juglans regia L.) counteracts A172 glioblastoma cell survival and bacterial growth 116
Amyloid beta(1-42) and its beta(25-35) fragment induce activation and membrane translocation of cytosolic phospholipase A2 in retina capillary pericytes 114
Melanogenesis in uveal melanoma cells: Effect of argan oil 113
Polymeric Nanoparticles Delivering Ferulic Acid for Potential Ocular Application 113
Potential therapeutic applications of mesenchymal stem cells for the treatment of eye diseases 113
Amyloid beta(1-42) and its beta(25-35) fragment induce activation and membrane translocation of cytosolic phospholipase A(2) in bovine retina capillary pericytes 111
Amyloid b(1-42) and its b(25-35) fragment induce activation and membrane translocation of cytosolic phospholipase A2 in retina capillary pericytes 111
The gaugaa motif is responsible for the binding between circsmarca5 and srsf1 and related downstream effects on glioblastoma multiforme cell migration and angiogenic potential 111
Hypoxia-Induced Inflammation in In Vitro Model of Human Blood–Brain Barrier: Modulatory Effects of the Olfactory Ensheathing Cell-Conditioned Medium 110
The analysis of miRNA expression profiling datasets reveals inverse microRNA patterns in glioblastoma and Alzheimer's disease 110
Pericytes in microvessels: From “mural” function to brain and retina regeneration 109
Topical administration of melatonin-loaded lipid-polymer hybrid nanoparticles for posterior segment eye diseases 109
Ferulic Acid-Loaded Polymeric Nanoparticles for Potential Ocular Delivery 108
E. Coli infection impairs insulin secretion through a Pla2-dependent mechanism 106
VEGF receptor-1 involvement in pericyte loss induced by Escherichia coli in an in vitro model of blood brain barrier 105
MAPKs mediate activation of cytosolic phospholipase A2 by amyloid β(25-35) peptide in bovine retina pericytes 105
Vitamin D3 preserves blood retinal barrier integrity in an in vitro model of diabetic retinopathy 104
VEGF receptor-1 involvement in the pericyte loss induced by E. coli in an in vitro model of blood brain barrier 104
Polyphenols in Inner Ear Neurobiology, Health and Disease: From Bench to Clinics 102
Immobilisation of neurotrophin peptides on gold nanoparticles by direct and lipid-mediated interaction: a new multipotential therapeutic nanoplatform for CNS disorders 101
Amyloid β but not bradykinin induces phosphatidylcholine hydrolysis in immortalized rat brain endothelial cells 100
Haloperidol Metabolite II Valproate Ester: Antiangiogenic Activity in Human Microvascular Retinal Endothelial Cells 100
Endothelial PKCα-MAPK/ERK-phospholipase A2 pathway activation as a response of glioma in a triple culture model. A new role for pericytes? 100
Protective Effects of Human Pericyte-like Adipose-Derived Mesenchymal Stem Cells on Human Retinal Endothelial Cells in an In Vitro Model of Diabetic Retinopathy: Evidence for Autologous Cell Therapy 100
Poly 2-methacryloyloxyethyl Phosphorylcholine Protects Corneal Cells and Contact Lenses from Desiccation Damage 99
Involvement of PKCa-MAPK/ERK-phospholipase A(2) pathway in the Escherichia coli invasion of brain microvascular endothelial cells 99
Novel indole derivatives targeting HuR-mRNA complex to counteract high glucose damage in retinal endothelial cells 99
t-Butyl hydroperoxide and oxidized low density lipoprotein enhance phospholipid hydrolysis in lipopolysaccharide-stimulated retinal pericytes 98
Expression of Ca2+-independent and Ca2+-dependent phospholipases A(2) and cyclooxygenases in human melanocytes and malignant melanoma cell lines 98
Brain endothelial cell-retinal pericyte co-cultures induce cytosolic phospholipase A2 protein expression through activation of PKCa and d isoforms and MAPK/ERK cascade 94
Klebsiella pneumoniae induces an inflammatory response in an in vitro model of blood-retinal barrier 92
Assessing the impact of e-cigarettes on human barrier systems: a systematic review 91
Molecular mechanisms mediating anti-angiogenic action of the urokinase receptor-derived peptide UPARANT in human retinal endothelial cells 91
Endothelial cell-pericyte cocultures induce PLA2 protein expression through activation of PKCα and the MAPK/ERK cascade 91
Atropine differentially modulates ECM production by ocular fibroblasts, and its ocular surface toxicity is blunted by colostrum 90
Molecular Mechanisms and Therapeutic Implications of Human Pericyte-like Adipose-Derived Mesenchymal Stem Cells in an In Vitro Model of Diabetic Retinopathy 90
Role of phospholipases A2 in diabetic retinopathy: in vitro and in vivo studies. 89
Ferritin-supported lipid bilayers for triggering the endothelial cell response 86
Neurotrophin-like peptides at the interface with gold nanoparticles as new nanoplatform for CNS disorders 85
PKCalpha-MAPK/ERK-phospholipase A2 signaling is required for human melanoma-enhanced brain endothelial cell proliferation and motility 84
Cytosolic and calcium-independent phospholipase A(2) mediate glioma-enhanced proangiogenic activity of brain endothelial cells. 84
Role of cytosolic and calcium independent phospholipases A2 in insulin secretion impairment of INS-1E cells infected by S. aureus 84
Pericyte adhesion and growth onto polyhydroxymethylsiloxane surfaces nanostructured by plasma treatment and ion irradiation 82
Lipid peroxidation inhibits oleoyl-CoA:1-acyl-sn-glycero-3-phosphocholine O-acyltransferase in rat CNS axolemma-enriched fractions 82
Comparative Efficiency of Lutein and Astaxanthin in the Protection of Human Corneal Epithelial Cells In Vitro from Blue-Violet Light Photo-Oxidative Damage 82
Pericytes of Stria Vascularis Are Targets of Cisplatin-Induced Ototoxicity: New Insights into the Molecular Mechanisms Involved in Blood-Labyrinth Barrier Breakdown 81
Ixazomib inhibits osteoclastogenesis and promotes osteogenic differentiation in vitro 81
Totale 12.776
Categoria #
all - tutte 50.476
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.476


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021448 0 0 0 0 0 22 85 11 105 2 119 104
2021/20221.093 117 147 14 33 168 31 178 43 80 22 31 229
2022/20231.927 157 127 51 228 197 284 21 336 410 20 52 44
2023/20241.073 55 144 37 35 35 323 18 85 14 25 163 139
2024/20253.612 65 578 263 218 733 399 189 144 197 330 278 218
2025/20266.398 513 678 1.786 560 1.241 1.620 0 0 0 0 0 0
Totale 16.063